MetaCap

Basel Medical Group (BMGL) vs Nakamoto (NAKA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Nakamoto is the larger company by market cap ($159.8 million vs $5.7 million), about 28.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

BMGL versus NAKA key metrics
MetricBMGLNAKA
Share price$3.60$8.93
Market cap$5.70M$159.80M
1-day change+9.76%-4.39%
YTD return—-33.48%
1-year return—-77.11%
P/E ratio (TTM)—4.78
EPS (TTM)$-4.98$1.87
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$21.72$42.00
52-week low$2.56$3.33
Distance from 52-week high-83.43%-78.74%
Analyst consensus—none
Avg. price target upside—+49.27%
Average volume529.72K202.82K
Shares outstanding1.58M17.89M
Employees—33
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Nakamoto is about 28.1 times larger than Basel Medical Group by market value ($159.80M vs $5.70M).

About Nakamoto

NAKA stock →

Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies.

Health Care · Medical/Nursing Services · 33 employees

BMGL vs NAKA FAQ

Which is bigger, Basel Medical Group or Nakamoto?

Nakamoto (NAKA) is larger, with a market capitalization of $159.80M compared with $5.70M for Basel Medical Group (BMGL).

Are Basel Medical Group and Nakamoto in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons